Gabriele M. Cerrone - 18 Mar 2026 Form 3 Insider Report for Tiziana Life Sciences Ltd (TLSA)

Reporting relationship
Director, 10%+ Owner
Issuer ticker
TLSA
Reported as of
18 Mar 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
3
Accepted by SEC
18 Mar 2026, 21:18:18 UTC
Prior SEC filing
16 Jun 2025
Next SEC filing
10 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Gabriele Cerrone

Key filing fact

Gabriele M. Cerrone filed Form 3 for Tiziana Life Sciences Ltd (TLSA) on 18 Mar 2026.

Key facts

  • This page summarizes Gabriele M. Cerrone's Form 3 filing for Tiziana Life Sciences Ltd (TLSA).
  • 0 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 18 Mar 2026, 21:18.

Change

  • Previous filing in this sequence was filed on 16 Jun 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001139306 Primary reporting owner

CERRONE GABRIELE M

Relationship
Director, 10%+ Owner
Address
C/O TIZIANA LIFESCIENCES LTD, 14-15 CONDUIT STREET, LONDON, UNITED KINGDOM
Signature
/s/ Gabriele Cerrone
Signature date
18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TLSA holding

COMMON STOCK

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
44,654,830
Date
18 Mar 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TLSA holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Common stock
Underlying amount
1,629,702
Exercise price
$0.8800
Footnotes
F1
TLSA holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Common stock
Underlying amount
250,000
Exercise price
$0.7100
TLSA holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Common stock
Underlying amount
250,000
Exercise price
$0.7100
TLSA holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Common stock
Underlying amount
250,000
Exercise price
$0.7100
TLSA holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Common stock
Underlying amount
250,000
Exercise price
$0.7100
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Exercisable upon the achievement of certain performance conditions

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .